Načítá se...
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
BACKGROUND & AIMS: Antiviral treatment is known to improve survival in patients with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB patients remains low. We aimed to report the secular trend in antiviral treatment uptake from 2007–2017, and to...
Uloženo v:
| Vydáno v: | JHEP Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7530304/ https://ncbi.nlm.nih.gov/pubmed/33024950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100152 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|